Eribulin mesylate 1 MG/2 ML VL 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCT3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,997
Award facts
- Contract value 100% obligated
- $41,996.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $41,996.53 to AmerisourceBergen Drug Corp for the supply of Eribulin Mesylate 1 mg/2 mL vials. This competitively awarded, firm fixed-price delivery order was issued on December 5, 2025, with an ultimate completion date of December 8, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 million prime vendor agreement valued through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems.
Eribulin Mesylate is a chemotherapy agent used in cancer treatment, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies through its DLA contracts. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies supporting Defense Health Agency and military healthcare operations. This delivery order represents a routine transactional award under the larger global pharmaceutical support vehicle, consistent with AmerisourceBergen's role as a primary supplier within the DLA Medical Supply Chain serving military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCT3A?
SPE2DR26FCT3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FCT3A worth?
The government has obligated $41,997 on SPE2DR26FCT3A.
Is contract SPE2DR26FCT3A an order under another contract?
Yes. SPE2DR26FCT3A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT3A competed?
The extent of competition for SPE2DR26FCT3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award